EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations

Alessandro De Angelis iD, Vittoria Comellini, Andrea Gramegna, Salvatore Battaglia iD, Giuliano Montemurro, Angela Bellofiore, Francesco Pagnini, Emilia Privitera, Margherita Ori, Edoardo Simonetta, Mattia Nigro iD, James D Chalmers und 3 weitere

Therapeutic Advances in Respiratory Disease · 2026-07 · 20

DOI: 10.1177/17534666261459923 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 04.07.2026. Verfasst von Alessandro De Angelis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Hauptthemen laut MEDLINE: Bronchiectasis, Guideline Adherence, Practice Guidelines as Topic, Practice Patterns, Physicians'. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

National quality standards for bronchiectasis in Italy were last defined in 2016. The publication of the 2025 European Respiratory Society (ERS) guidelines offers the opportunity to evaluate current clinical practice against updated evidence-based recommendations.

Objectives

To assess the extent to which Italian bronchiectasis centers align with key statements from the 2025 ERS guidelines.

Design

National, multicenter, cross-sectional observational study based on a structured survey of Italian bronchiectasis centers, aligned with the 2025 ERS recommendations.

Methods

A national survey was conducted across Italian bronchiectasis centers affiliated with the Italian Bronchiectasis Patient Association (AIB). The structured questionnaire assessed center organization, diagnostic resources, multidisciplinary care, and alignment with ten predefined core management domains derived from the 2025 ERS recommendations.

Results

Most centers reported universal access to minimum bundle etiological tests, with improved capacity compared with 2016. However, specialized diagnostics for rare causes, structured physiotherapy programs, and written self-management plans remain inconsistently available. Long-term inhaled antibiotics and macrolides were widely prescribed, though access barriers persist. Monitoring practices were heterogeneous.

Conclusion

Despite clear progress, substantial variability persists in physiotherapy access, rare disease diagnostics, self-management tools, and routine monitoring. Updated Italian quality standards aligned with ERS 2025 principles are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchiectasisGuideline AdherencePractice Guidelines as TopicPractice Patterns, Physicians'Quality Indicators, Health CareHumansItalyCross-Sectional StudiesAnti-Bacterial AgentsPhysical Therapy ModalitiesHealth Care SurveysSocieties, MedicalSurveys and QuestionnairesHealth Services Accessibility

Stichwörter der Autor:innen

bronchiectasisclinical networkshealthcare organizationstandard operating procedures

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Respiratory Unit, Rozzano, Milan, Italy.
  • Respiratory and Critical Care Unit, IRCCS Sant'Orsola Malpighi Hospital, Bologna, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Internal Medicine Department, Respiratory and Cystic Fibrosis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy.

ORCID-Profile: Alessandro De Angelis, Salvatore Battaglia, Mattia Nigro

Zitieren

APA

De Angelis, A., Comellini, V., Gramegna, A., Battaglia, S., Montemurro, G., Bellofiore, A., Pagnini, F., Privitera, E., Ori, M., Simonetta, E., Nigro, M., Chalmers, J. D., Nobile, D., Blasi, F., & Aliberti, S. (2026). Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261459923

Vancouver

De Angelis A, Comellini V, Gramegna A, Battaglia S, Montemurro G, Bellofiore A, et al. Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261459923

BibTeX
@article{DeAngelis2026,
  author = {De Angelis, Alessandro and Comellini, Vittoria and Gramegna, Andrea and Battaglia, Salvatore and Montemurro, Giuliano and Bellofiore, Angela and Pagnini, Francesco and Privitera, Emilia and Ori, Margherita and Simonetta, Edoardo and Nigro, Mattia and Chalmers, James D and Nobile, Donatella and Blasi, Francesco and Aliberti, Stefano},
  title = {Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17534666261459923}
}
Kostenlos starten →